• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Elevai Labs, Inc. - Common Stock (NQ: ELAB )

0.0289 -0.0301 (-51.02%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 202,280,913
Open 0.0385
Bid (Size) 0.0285 (735)
Ask (Size) 0.0290 (407)
Prev. Close 0.0590
Today's Range 0.0283 - 0.0399
52wk Range 0.0283 - 4.244
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Dow Jumps 400 Points; US Adds 12,000 Jobs In October
November 01, 2024
Via Benzinga
Topics Stocks
Exposures US Equities
Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
November 01, 2024
Via Benzinga

Performance

YTD
-98.47%
-98.47%
1 Month
-78.11%
-78.11%
3 Month
-91.35%
-91.35%
6 Month
-95.63%
-95.63%
1 Year
-99.15%
-99.15%

More News

Read More
Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
October 31, 2024
Via Benzinga
12 Consumer Staples Stocks Moving In Friday's Intraday Session
October 25, 2024
Via Benzinga
Why Elevai Labs (ELAB) Stock Is Down 60% Today
September 23, 2024
Via Benzinga
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity
October 22, 2024
From Elevai Labs Inc.
Via GlobeNewswire
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity
October 21, 2024
From Elevai Labs Inc.
Via GlobeNewswire
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
October 10, 2024
Via Benzinga
Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock
October 04, 2024
From Elevai Labs Inc.
Via GlobeNewswire
12 Consumer Staples Stocks Moving In Friday's After-Market Session
October 04, 2024
Via Benzinga
11 Consumer Staples Stocks Moving In Friday's Intraday Session
October 04, 2024
Via Benzinga
Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket
October 04, 2024
Via Benzinga
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
October 03, 2024
Via Benzinga
REPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations
October 03, 2024
From Elevai Labs Inc.
Via GlobeNewswire
Nasdaq Moves Lower; Levi Strauss Shares Slide
October 03, 2024
Via Benzinga
Crude Oil Jumps Over 4%; US Services PMI Revised Lower
October 03, 2024
Via Benzinga
Exposures Fossil Fuels
Dow Dips Over 100 Points; US Jobless Claims Increase To 225,000
October 03, 2024
Via Benzinga
Topics Stocks
Exposures US Equities
12 Consumer Staples Stocks Moving In Thursday's Pre-Market Session
October 03, 2024
Via Benzinga
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations
October 03, 2024
From Elevai Labs Inc.
Via GlobeNewswire
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy Device
October 02, 2024
From Elevai Labs Inc.
Via GlobeNewswire
7 Penny Stocks to Watch Now: ELAB, RJDG, BTTC, ATCH, CBDW, and More!
September 25, 2024
Via AB Newswire
Dow Gains Over 50 Points; Elevai Labs Shares Plummet
September 23, 2024
Via Benzinga
Topics Stocks
Exposures US Equities
Crude Oil Down Over 1%; US Manufacturing PMI Falls In September
September 23, 2024
Via Benzinga
Exposures Fossil Fuels
US Stocks Edge Higher; Chicago Fed National Activity Increases In August
September 23, 2024
Via Benzinga
Topics Economy
Exposures Interest Rates
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering
September 23, 2024
From Elevai Labs Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap